發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

__    __    _____      _____    _____     ______  
\ \\ / //  |  ___||   / ___//  |  ___||  /_   _// 
 \ \/ //   | ||__     \___ \\  | ||__    `-| |,-  
  \  //    | ||__     /    //  | ||__      | ||   
   \//     |_____||  /____//   |_____||    |_||   
    `      `-----`  `-----`    `-----`     `-`'